FDAFDA · Food and drugs·Recall number D-0573-2022
Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01
Published March 2, 2022 · Recall initiated: February 7, 2022
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- METHYLPHENIDATE HYDROCHLORIDE
- Manufacturer
- RISING PHARMACEUTICALS
- Distributor
- Nationwide in the USA
- Lot
- lot# 25910009, Exp 01/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.